Morimoto Masahiro, Matsui Eiko, Kawamoto Norio, Sakurai Satomi, Kaneko Hideo, Fukao Toshiyuki, Iwasa Shinichi, Shiraki Makoto, Kasahara Kimiko, Kondo Naomi
Department of Pediatrics, Graduate School of Medicine, Gifu University, Gifu, Japan.
Allergol Int. 2009 Mar;58(1):97-102. doi: 10.2332/allergolint.O-07-530. Epub 2009 Jan 25.
Transforming growth factor beta1 (TGF beta 1) is an important factor in immunomodulation. The expression of TGF beta 1 has been shown to be influenced by the C-509T polymorphism in the TGF beta 1 gene. We investigated age-related changes of plasma TGF beta 1 levels in a birth-cohort study. In addition, the genotypes of the C-509T polymorphism were investigated in allergic and non-allergic subjects.
Sixty-four neonates who met the following criteria were enrolled in this cohort study: 1) full-term vaginally delivery; 2) underwent DNA polymorphism analysis; and 3) questionnaire forms were filled out by parents at 0, 6 and 14 months of age. The umbilical cord blood at 0 months and peripheral blood at 6, and 14 months were collected. Plasma TGF beta1 levels were measured at 0, 6 and 14 months of age. Genomic DNA was extracted from their umbilical cord blood. The genotype of the subjects was examined for the presence of C-509T.
The plasma TGF beta 1 level at 6 months was the highest of the 3 measurements (at 0, 6, and 14 months of age). The TGF beta 1 levels at 14 months in allergic subjects were significantly higher than those in non-allergic subjects (p = 0.03). All subjects with bronchial asthma (n = 3) had the TT genotype of the C-509T polymorphism.
The plasma TGF beta 1 levels change with age. In addition, TGF beta 1 may play a role in the pathogenesis of bronchial asthma.